Congress of psychiatry
Patients with high levels of brain-derived
Download 0.5 Mb. Pdf ko'rish
|
|
003 Patients with high levels of brain-derived neurotrophic factor (BDNF) show a normalization of memory impairment during antidepressant treatment Jan Engelmann, Germany Stefanie Wagner, Konrad Schlicht, Nadine Dreimüller, Marianne B. Müller, André Tadic, Klaus Lieb 004 Deleterious effects of antidepressants on semen parameters: a case report Khalid Shehatto, Egypt Manal Abed, Ahmed El-Aghoury 005 Usefulness of intravenous clomipramine on in- patients with refractory major depressive disorder Kazuaki Sugawara, Japan Toshiyuki Kobayashi 006 Can mirtazapine and bupropion be alternative medicines for depressed patients at risk for bleeding? Han-Yong Jung, Republic of Korea Se-Hoon Shim, Kyoung-Sae Na 007 ECT has greater efficacy than fluoxetine in alle- viating the burden of illness for patients with major depressive disorder – a Taiwanese pooled analysis Ching-Hua Lin, Taiwan Ming-Chao Chen, Fu-Chiang Wang 008 Effect of vortioxetine versus paroxetina on sexual functioning Esther Mancha Heredero, Spain María Jesús Leñero Navarrete, Yanira D'Hiver Cantalejo, Héctor Saiz García, Cristina Blanco Dorado, Angela Sofía Rosero Enríquez, Alejandro Ballesteros Prados 009 Drug interactions in chronic pain disorder, addiction and affective disorder – clinic, treatment and TDM Ivana Adamovic, Germany 010 Readmissions for bipolar affective disorder: pharmacological approach at discharge in a special- ized unit in Lisbon Marco Gonçalves, Portugal Inês Coelho, Miguel Nascimento, Mariana Silva, Joana Aguiar 011 Alpha1 and alpha2 adrenoceptors as targets of antidepressant and antipsychotic drugs: insights from serum reference levels and in vitro-binding affinity patterns Tabea von der Lühe, Germany Julia Christl, Christian Lange-Asschenfeldt 012 A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist – odelepran the treatment of alcohol addiction Elvira Mukhamettshina, Russia 013 Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patience with alcohol use disorder: relationship with haloperidol plasmatic concentration, efficacy of pharmacotherapy and risk of adverse drug reactions Mikhail Zastrozhin, Russia Dmitry Sychev, Igor Miroshnichenko, Elena Grishina, Valery Smirnov, Evgeny Bryun 014 New safety signals Annette Viktoria Hinze, Germany Walburga Lütkehermölle, Martin Huber, Christine Greiner 015 Characteristics of severe hyponatremia in pa- tients with psychiatric illness: a retrospective study Eriko Makino, Japan Tetsuro Enomoto, Takahide Hashimoto, Hidetaka Hamasaki, Akahito Sako, Hidekatsu Yanai, Hideki Nanasawa, Tatsuro Hayakawa P-35 Poster Session 13:30 – 15:00 | Hall Budapest TOPIC 18: Pharmacotherapy Pharmacotherapy II Chair: Ekkehard Haen, Germany 001 A study to assess the prophylactic and ther- apeutic effect of enalapril on olanzapine-induced metabolic syndrome in wistar rats Veena Nayak, India Avinash A., Kurady Laxminarayana Bairy, Sushil Kiran Kunder 002 May quetiapine plus sertraline cause bell's palsy? Two case reports Mohammadreza Shalbafan, Iran Farzaneh Malekpour 003 Predictors of response to celecoxib augmen- tation of olanzapine therapy in schizophrenia in a randomized, double blind, controlled study Kabir Garg, India Anil Nischal, Anuradha Nischal, Adarsh Tripathi, Manu Agarwal 004 Relationship between antipsychotic treatment and metabolic parameters in a group of patients with severe mental disorder and sedentary lifestyle Luisa San Emeterio, Spain M. Teresa Salvador, Silvia Oller, Luis Miguel Martin, Roser Masa, M. Isabel Fernandez MOND A Y TUESD A Y WEDNESD A Y THURSD A Y POSTER SESSIONS 276 005 Sustained remission and symptomatic stability among patients with schizophrenia receiving aripiprazole once-monthly in a 52-week, open-label, maintenance study Timothy Peters-Strickland, USA Na Jin, Pedro Such, Phyllis M. Salzman 006 Priapism following augmentation treatment with quetiapine: a case report Razan Alkhoury, Germany Marius Bolten, Gisbert Eikmeier 007 A randomized controlled trial of pharmacist intervention on cognitive outcomes in patients with schizophrenia Thanarat Suansanae, Thailand Thanompong Sathienluckana, Weerapon Unaharassamee, Oraporn Suanchang, Chuthamanee Suthisisang 008 Evaluation of clozapine total clearance from therapeutic drug monitoring data Melissa Ballestrin, Italy Ekkehard Haen 009 Outpatient's clozapine initiation at treatment resistant schizophrenic patients in a rural Greek hospital: protocol – results Argitis Petros, Greece Konstantina Mpaklori, Sofia Skopelitou, Paraskevi Platari, Andreas Karampas, Anthi Plevritaki, Lampros Sakkas, Maria Poulou 010 Eosinophilia secondary to clozapine: about a case Mónica Rodríguez Merino, Spain Jorge Schoendorff Ortega, Juan José Arechederra Aranzadi, Mariano Hernández Herreros, Ana Judith Mesa Suárez, Luis Enrique Vidal Palmer, María Inéz López-Ibor 011 Treatment with haloperidol in the light of current efficacy and safety knowledge Christine Greiner, Germany Annette Viktoria Hinze, Martin Huber 012 Lumateperone (ITI-007): a unique investiga- tional agent with broad therapeutic potential across neuropsychiatric disorders Cedric O'Gorman, USA Kimberly Vanover, Christoph U. Correll, Steve Glass, Sharon Mates, Jelena Saillard, Michal Weingart, Robert Davis 013 A retrospective analysis of antipsychotic combination vs. monotherapy treatment in a long term psychiatric facility Jose Rey, USA Yesenia Sanin, Stepan Uhlyar 014 Drug-induced parkinsonism among patients receiving anti-psychotic medications in a Nigerian hospital Fatima Olaiya, Nigeria Champion Seun-Fadipe, Kolawole Mosaku 015 Medication discrepancies among demented persons in home care settings with or without treatment by a neurologist Leonhard Schütz, Germany Nils Lahmann, Ralf Suhr, Xavier Boronat-Garrido, Fabian Alexander Moser P-36 Poster Session 13:30 – 15:00 | Hall Budapest TOPIC 18: Pharmacotherapy Pharmacotherapy III Chair: Christoph Hiemke, Germany 001 Safety of DPP-4 inhibitor on anxiety and depression among type 2 diabetes: a systematic review and network meta-analysis Weiwei Wang, People's Republic of China Feng Sun, Shanshan Wu, Siyan Zhan 002 Protocol for the evaluation of the physiochem- ical properties of 3 generic psychotropic essential medications in South-South Nigeria Frances Adiukwu, Nigeria Chidozie Chukwujekwu, Ibipiriene Wakama, Princewill Stanley 003 A meta-analysis of the efficacy of silexan in subthreshold anxiety Stephan Klement, Germany Hans-Peter Volz, Siegfried Kasper 004 Comparison of anxiolytic effects of the homeo- pathic complex vita-C 15 in compared with aconi- tum napellus in the acutely stressed C57BL6 mice Charis Liew, Malaysia 005 In silico and in vitro study of bromdihydro- chlorphenylbenzodiazepines – Russian original benzodiazepine-metabolical pathways Dmitriy Ivashchenko, Russia Andrey Poloznikov, D. A. Filimonov, Sergey Nikulin, A. V. Rudik, Alexander Dmitriev, Lyudmila Savchenko, Eugeniy Bryun 006 Memantine augmentation improves symptoms in patients with treatment-refractory obsessive- compulsive disorder: a randomized controlled trial Setareh Razoughi, Iran Mehdi Sayyah, Leila Kouti, Kaveh Eslami 007 Efficacy of intravenous ketamine for treatment of acute post traumatic stress disorder Achyut Trivedi, India Ashok Singhal MOND A Y TUESD A Y WEDNESD A Y THURSD A Y POSTER SESSIONS 277 German language Session 008 Efficacy and tolerability of amitriptyline versus fluoxetine in the treatment of patients with somato- form disorder: a randomized comparative trial Sulochana Joshi, Nepal Arun Kumar Pandey, Nidesh Sapkota 009 Effects of Neurexan ® on reduced stress respon- sivity in the autonomic nervous system measured by heart rate variability Hamidreza Jamalabadi, Germany Tara Chand, Sarah Alizadeh, Myron Schultz, Martin Walter 010 Effects of Neurexan ® on brain responses to deviant stimuli during an auditory oddball task Sarah Alizadeh, Germany Galina Surova, Hamidreza Jamalabadi, Myron Schultz, Martin Walter 011 Dronabinol tincture and its effect on Gille de la Tourette syndrome – a case report Eva-Maria Pichler, Austria Wolfram Kawohl 012 Drug interactions: antiretroviral and psychotropics Daniel de Aquino Leite, Brazil Lino Marcos Zanatta, Adib Subhi Hasan Husein, Adriana Maria Sousa 013 Meta-analyses on the pharmacokinetics of donepezil Frank Faltraco, Germany Daniel Reker, Martin Heinze P-37 Poster Session 13:30 – 15:00 | Hall Budapest TOPIC 19: Stimulation methods and interdisciplinary interventions Stimulation methods and interdisciplinary interven- tions Chair: Michael Grözinger, Germany 001 Changes in self-perception in patients, treated with neuro-stimulating devices Simon Eich, Germany Oliver Müller, Andreas Schulze-Bonhage 002 Repetitive peripheral magnetic stimulation (rPMS) can improve mood of patients with brain insults Adel Marei, Egypt Hebatallah Rashed 003 Combining repetitive transcranial magnetic stimulation and cognitive behavioral therapy for effective treatment of tinnitus and insomnia – a case report Lukas Peter, Germany Kneginja Richter, Jens Acker, Joachim Höfig, Lence Miloseva, Günter Niklewski 004 The differential effects of monophasic and biphasic repetitive transcranial magnetic stimula- tion on attentional processing in major depressive disorder Molly Hyde, Canada Pierre Blier, Lisa McMurray, Ahmed Rostom, Asif Khan, Verner Knott 005 Modulation of cognitive flexibility through transcranial direct current stimulation Elisabeth Hertenstein, Germany Lukas Frase, Elena Waibel, Dieter Riemann, Christoph Nissen 006 rTMS and ECT: are they combinable? Case reports of nine patients Samir Ibrahim, Australia Paul Fitzgerald 007 Personnel's attitude towards reintroducing electroconvulsive therapy – the baseline assessment Deborah Scholz-Hehn, Germany Jana Christina Müller, Ruben Deml, Heiko Albrecht, Daniel Luedecke, Janina Katharina Gornisch, Laura Stumm, Nils Freundlieb 008 Effects of low amplitude EEG recordings during electroconvulsive therapy (ECT) on electronic and manual assessments of post suppression indices (PSI) in geriatric patients Andreas Raether, Germany Christopher Dedner, Karin Ademmer 009 Successful treatment of super-refractory status epilepticus with high-intensity electroconvulsive therapy: a case report Hanna Schneegans, Germany Henning Stetefeld, Christian Dohmen, Özgür Onur, Fritz-Georg Lehnhardt 010 Satisfaction with electroconvulsive therapy (ECT) – retrospective view of patients and their relatives Lucie Kalisova, Czech Republic Marketa Kubinova, Jiri Michalec, Katerina Madlova, Jakub Albrecht 011 Efficacy and safety of ECT in a 16-year old ado- lescent with chronic catatonia: case presentation Holger Himmighoffen, Switzerland Annette Beatrix Brühl 012 Effectiveness of aerobic exercise and biofeed- back therapy in tension type head ache: a compara- tive study Indira Sharma, India Anil Gour 013 The effect of mind-body exercise on quitting illicit drug use: a systematic review Chian-Feng Huang, Taiwan Chia-Hsiang Chan MOND A Y TUESD A Y WEDNESD A Y THURSD A Y POSTER SESSIONS 278 014 Didactic musical composition on bipolar disorder Erico Kohl, Brazil Altino Bessa Marques Filho, José Antonio Cordeiro, Victor Hugo Ferreira Silva 015 Social determinants as focus in the treatment of mild mental retardation – a case report Pedro de Freitas Skaff Zaidan, Brazil Juliana Andrade Brito Lins, Ricardo Azevedo Pacheco, Thais Baer, Vanessa Regina Carli, Guilherme Passamani Borges, Heitor Prates Furieri, Pablo Alves da Silva Zunini 016 Treatment effects on automatic emotion pro- cessing in major depressive disorder Ronny Redlich, Germany Dario Zaremba, Katharina Dohm, Katharina Förster, Susanne Meinert, Elisabeth Leehr, Joscha Böhnlein, Jonathan Repple, Christian Bürger, Dominik Grotegerd, Nils Opel, Udo Dannlowski P-38 Poster Session 13:30 – 15:00 | Hall Budapest TOPIC 20: Prevention and health promotion Prevention and health promotion Chair: Johannes Wancata, Austria 001 Protocol for a Cochrane review and meta-analy- sis: psychological interventions for resilience en- hancement in adults Angela Kunzler, Germany Isabella Helmreich, Andrea Chmitorz, Jochem König, Harald Binder, Michèle Wessa, Klaus Lieb 002 Population-based validation of a German version of the brief resilience scale Andrea Chmitorz, Germany Angela Kunzler, Rolf-Dieter Stieglitz, Mario Wenzel, Isabella Helmreich, Anna Gerlicher, Miriam Kampa, Thomas Kubiak, Raffael Kalisch, Klaus Lieb, Oliver Tüscher 003 Attachment security to mother and father figures and association with bully/victim behaviour in a large adolescent sample Frida Dahlbäck, Sweden Birgitta Kerstis, Cecilia Åslund, Karin Sonnby 004 Preventing attachment disorder through a mother-child dyadic group therapy – an 18 month follow-up of a high risk population Maria Eugenia Herrero, Spain Ainara Temprano, Carlos Justo, Ana Iniesta, Cesar Martinez 005 Smoking bans in mental health hospitals in Japan: barriers to implementation Kazumichi Hashimoto, Japan Manabu Makinodan, Yasuhiro Matsuda, Tsubasa Morimoto, Shotaro Ueda, Toshifumi Kishimoto 006 50 ways to prevent a schizophrenia relapse – which are put into practice? Susanne Jaeger, Germany Patricia Bückle, Tilman Steinert 007 The targets of the prevention non-psychotic mental disorders in medical students Iryna Leshchyna, Ukraine Tetiana Mozgova 008 How does a depressive and anxious symptom- atology influence the intention of infertile couples to persist in fertility treatments? Jose Temotio, Portugal Inês Marques, Maria Balreira 009 Children's daily lives survey using modified QCD questionnaire in Ishinomaki, tsunami devastated area of East Japan earthquake, 4 years follow-up Naoko Satake, Japan 010 Feasibility and acceptability of a prevention program for eating disorders (me, you and us) adapted for young adolescents in Korea Youl-Ri Kim, Republic of Korea Gi Young Lee, Eun Jin Park, Kyung Hwa Kwag, Jin Hong Park, So Hyun An, Ji Hyun Lee, Jeong Hun Sim, Janet Treasure 011 Joint crisis plans in psychiatric practice Katrin Radenbach, Germany Detlef Degner, Alfred Simon 012 Caregiver's burden and anxiety in epilepsy Pelin Su Sirin, Turkey Kumru Senyasar Meterelliyoz, Dilek Atakli 013 Clinical differences between patients who undergo surgery for morbid obesity and patients who reject the intervention María Suárez Gómez, Portugal Ana Paula Matos Pires, Francisco José Vaz-Leal, Juan Antonio Guisado-Macías, Mariano Casado-Blanco, Laura Rodríguez-Santos, M. Isabel Ramos-Fuentes, Beatriz Bajo-Cabello P-39 (d) Poster Session 13:30 – 15:00 | Hall Budapest TOPIC 22: Community and social psychiatry Ambulante Versorgung und Rehabilitation Chair: Ronald Burian, Germany 001 Effekte der Konsiliar- und Liaison-Psychiatrie für eine erstmalige psychiatrische Behandlung Torsten Hoffmann, Switzerland MOND A Y TUESD A Y WEDNESD A Y THURSD A Y POSTER SESSIONS 279 German language Session 002 Brückenteam – Psychiatrisches Überleitungs- management in der Allgemeinpsychiatrie an der Ausgangstüre einer Versorgungsklinik Ruth Weizel, Germany 003 Wie wirken sich ambulante Eingliederungs- hilfeleistungen auf die Teilhabechancen chronisch psychisch erkrankter Menschen aus? Eine qualitati- ve Studie zur ambulanten Sozialpsychiatrie (ASP) in Hamburg Gesa Mayer, Germany Matthias Nauerth, Anneke Wiese 004 Nutzung ambulanter Behandlungs- und Hilfeangebote durch Schizophrenie kranke Menschen nach stationärer Behandlung Gerhard Längle, Germany Elisa Frei, Susanne Jaeger, Thomas Becker, Tilman Steinert, Reinhold Kilian 005 Können Kennzahlen aus dem operativen Controlling Abbrüche einer Behandlung in einer ambulanten Rehaklinik vorhersagen? Rafael Rabenstein, Austria Birgit Senft, Alexandra Schosser 006 Beschwerdenvalidierung in der psychosomati- schen Rehabilitation: der SFSS in einer klinischen Stichprobe Wolfgang Pfeiffer, Germany Daniela Gutermann, Markus Bassler 007 Kultursensible Gesundheitseinrichtungen – ein Scoping Review Oriana Handtke, Germany Benjamin Schilgen, Holger Schulz, Mike Mösko P-40 (d) Poster Session 13:30 – 15:00 | Hall Budapest TOPIC 17: Psychotherapy Psychotherapie und andere psychiatrische Therapieformen Chair: Bernhard Strauß, Germany 001 Bedarf eines Therapieangebots für Patienten der Psychodermatologie Lena Hinkelmann, Germany Nina Schulze, Peter Tonn 002 Metakognitives Gruppentraining bei Zwang – Ergebnisse einer Pilotstudie zu einer neu entwi- ckelten Gruppenintervention Birgit Hottenrott, Germany Lotta Zielke, Barbara Cludius, Lilian Krasberg, Cüneyt Demiralay, Anna Sure, Marit Hauschildt, Steffen Moritz, Lena Jelinek 003 Kooperation einer Universitätsklinik mit einer Jugendfarm und Umweltstation – schulenübergrei- fende tiergestützte Gruppentherapie Judith Walloch, Germany Maria Feuerstake, Johannes Kornhuber 004 Internettherapie für Hinterbliebene von Menschen mit hämatologischer Krebserkrankung Rahel Hoffmann, Germany Julia Große, Michaela Nagl, Anja Mehnert, Anette Kersting 005 Suchterkrankung und traumatisierende Lebenserfahrung – Evaluation eines Behandlungs- manuals für die (teil-)stationäre psychiatrische Behandlung Michael Müller-Mohnssen, Germany Waltraud Heiserer-Trautmann, Michaela Hafner-König, Bernhard Widmann, Thomas Fritschi Download 0.5 Mb. Do'stlaringiz bilan baham: 
|